Similar Papers

Paper Title
Journal
Date
Author
SOX9 is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition.
Jeffrey C Francis ... Johann de Bono
Oncotarget | VOL. 9
Jeffrey C Francis, et. al.Jeffrey C Francis ... Johann de Bono
10 Jan 2018
Data from Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations
Angelo M De Marzo ... Ruth Dumpit
-
Angelo M De Marzo, et. al.Angelo M De Marzo ... Ruth Dumpit
04 Apr 2023
Data from Comprehensive Assessment of Anaplastic Lymphoma Kinase in Localized and Metastatic Prostate Cancer Reveals Targetable Alterations
Lisa S Ang ... Gavin Ha
-
Lisa S Ang, et. al.Lisa S Ang ... Gavin Ha
04 Apr 2023
Abstract B35: Integrative nomination of prostate cancer driver genes from paired-end sequencing
Christina Stewart Pichot ... Mark P Hamilton
Cancer Research | VOL. 72
Christina Stewart Pichot, et. al.Christina Stewart Pichot ... Mark P Hamilton
06 Feb 2012
View more papers

More From: ACS Nanoscience Au

Paper Title
Journal
Date
Author
Phase Controlled Metalorganic Chemical Vapor Deposition Growth of Wafer-Scale Molybdenum Ditelluride
Bum Jun Kim ... Zakaria Y Al Balushi
ACS Nanoscience Au | VOL. -
Bum Jun Kim, et. al.Bum Jun Kim ... Zakaria Y Al Balushi
13 Jan 2025
Role of Heavy Water in the Synthesis and Nanocatalytic Activity of Gold Nanoparticles
Nathaniel E Larm ... Gary A Baker
ACS Nanoscience Au | VOL. -
Nathaniel E Larm, et. al.Nathaniel E Larm ... Gary A Baker
07 Jan 2025
Lipid Nanoparticle Delivery of mRNA and siRNA for Concurrent Restoration of Tumor Suppressor and Inhibition of Tumorigenic Driver in Prostate Cancer
Ryan A Farokhzad ... Jinjun Shi
ACS Nanoscience Au | VOL. -
Ryan A Farokhzad, et. al.Ryan A Farokhzad ... Jinjun Shi
26 Dec 2024
Issue Editorial Masthead
-
ACS Nanoscience Au | VOL. 4
--
18 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.